Results 221 to 230 of about 9,302 (232)

Teplizumab-related AEs reported to FAERS

Reactions Weekly
openaire   +1 more source

Tirofiban-related AEs reported to FAERS

Reactions Weekly
openaire   +1 more source

Tarlatamab-related AEs identified in FAERS

Reactions Weekly
openaire   +1 more source

Cabazitaxel-related AEs identified in FAERS

Reactions Weekly
openaire   +1 more source

Disproportionate adverse event signals of selumetinib in neurofibromatosis type I: insights from FAERS

Frontiers in Pharmacology
exaly  

Satralizumab-related AEs identified in FAERS

Reactions Weekly
openaire   +1 more source

Avacopan-related AEs identified in FAERS

Reactions Weekly
openaire   +1 more source

High-risk adverse events in two types of single inhaler triple-therapy: a pharmacovigilance study based on the FAERS database

Frontiers in Pharmacology
exaly  

Fruquintinib-related AEs identified in FAERS

Reactions Weekly
openaire   +1 more source

Tadalafil-related AEs identified in FAERS

Reactions Weekly
openaire   +1 more source